First new HIV vaccine efficacy study in 7 years has begun

(NIH/National Institute of Allergy and Infectious Diseases) The first HIV vaccine efficacy study to launch in seven years is testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus. HVTN 702 aims to enroll 5,400 men and women, making it the largest and most advanced HIV vaccine clinical trial to take place in South...